BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

218 related articles for article (PubMed ID: 10765938)

  • 1. Salivary gland lymphomas in patients with Sjögren's syndrome may frequently develop from rheumatoid factor B cells.
    Martin T; Weber JC; Levallois H; Labouret N; Soley A; Koenig S; Korganow AS; Pasquali JL
    Arthritis Rheum; 2000 Apr; 43(4):908-16. PubMed ID: 10765938
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Analysis of V(H)-D-J(H) gene transcripts in B cells infiltrating the salivary glands and lymph node tissues of patients with Sjögren's syndrome.
    Gellrich S; Rutz S; Borkowski A; Golembowski S; Gromnica-Ihle E; Sterry W; Jahn S
    Arthritis Rheum; 1999 Feb; 42(2):240-7. PubMed ID: 10025917
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Diminished peripheral blood memory B cells and accumulation of memory B cells in the salivary glands of patients with Sjögren's syndrome.
    Hansen A; Odendahl M; Reiter K; Jacobi AM; Feist E; Scholze J; Burmester GR; Lipsky PE; Dörner T
    Arthritis Rheum; 2002 Aug; 46(8):2160-71. PubMed ID: 12209521
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expression of a cross-reactive idiotype on rheumatoid factor in patients with Sjogren's syndrome.
    Fox RI; Chen P; Carson DA; Fong S
    J Immunol; 1986 Jan; 136(2):477-83. PubMed ID: 3079786
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Detection of clonally expanded salivary gland lymphocytes in Sjögren's syndrome.
    Freimark B; Fantozzi R; Bone R; Bordin G; Fox R
    Arthritis Rheum; 1989 Jul; 32(7):859-69. PubMed ID: 2546568
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Salivary gland B cell lymphoproliferative disorders in Sjögren's syndrome present a restricted use of antigen receptor gene segments similar to those used by hepatitis C virus-associated non-Hodgkins's lymphomas.
    De Re V; De Vita S; Gasparotto D; Marzotto A; Carbone A; Ferraccioli G; Boiocchi M
    Eur J Immunol; 2002 Mar; 32(3):903-10. PubMed ID: 11870635
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sjögren's syndrome in patients with newly diagnosed untreated non-Hodgkin's lymphoma.
    Andonopoulos AP; Tiniakou M; Melachrinou M; Sfountouris H; Bounas A; Zervas C; Zoumbos NC
    Rev Rhum Engl Ed; 1997 May; 64(5):287-92. PubMed ID: 9190001
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Extrasalivary lymphoma development in Sjögren's syndrome: clonal evolution from parotid gland lymphoproliferation and role of local triggering.
    Gasparotto D; De Vita S; De Re V; Marzotto A; De Marchi G; Scott CA; Gloghini A; Ferraccioli G; Boiocchi M
    Arthritis Rheum; 2003 Nov; 48(11):3181-6. PubMed ID: 14613281
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characterization of B cell lymphoma in patients with Sjögren's syndrome and hepatitis C virus infection.
    Ramos-Casals M; la Civita L; de Vita S; Solans R; Luppi M; Medina F; Caramaschi P; Fadda P; de Marchi G; Lopez-Guillermo A; Font J;
    Arthritis Rheum; 2007 Feb; 57(1):161-70. PubMed ID: 17266090
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Rates of infiltration by macrophages and dendritic cells and expression of interleukin-18 and interleukin-12 in the chronic inflammatory lesions of Sjögren's syndrome: correlation with certain features of immune hyperactivity and factors associated with high risk of lymphoma development.
    Manoussakis MN; Boiu S; Korkolopoulou P; Kapsogeorgou EK; Kavantzas N; Ziakas P; Patsouris E; Moutsopoulos HM
    Arthritis Rheum; 2007 Dec; 56(12):3977-88. PubMed ID: 18050195
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Autoantibody production in Sjögren's syndrome: a hypothesis regarding defects in somatic diversification of germ line encoded genes.
    Fox RI; Fong S; Chen PP; Kipps TJ
    In Vivo; 1988; 2(1):47-55. PubMed ID: 2979816
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dissemination of a Sjögren's syndrome-associated extranodal marginal-zone B cell lymphoma: circulating lymphoma cells and invariant mutation pattern of nodal Ig heavy- and light-chain variable-region gene rearrangements.
    Hansen A; Reiter K; Pruss A; Loddenkemper C; Kaufmann O; Jacobi AM; Scholze J; Lipsky PE; Dörner T
    Arthritis Rheum; 2006 Jan; 54(1):127-37. PubMed ID: 16385504
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Molecular characterization of a major autoantibody-associated cross-reactive idiotype in Sjogren's syndrome.
    Kipps TJ; Tomhave E; Chen PP; Fox RI
    J Immunol; 1989 Jun; 142(12):4261-8. PubMed ID: 2542406
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lymphoma development in Sjögren's syndrome: novel p53 mutations.
    Tapinos NI; Polihronis M; Moutsopoulos HM
    Arthritis Rheum; 1999 Jul; 42(7):1466-72. PubMed ID: 10403275
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Local cytokine expression in the progression toward B cell malignancy in Sjögren's syndrome.
    De Vita S; Dolcetti R; Ferraccioli G; Pivetta B; De Re V; Gloghini A; D'Agosto A; Bartoli E; Carbone A; Boiocchi M
    J Rheumatol; 1995 Sep; 22(9):1674-80. PubMed ID: 8523344
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The polymerase chain reaction detects B cell clonalities in patients with Sjögren's syndrome and suspected malignant lymphoma.
    De Vita S; Ferraccioli G; De Re V; Dolcetti R; Carbone A; Bartoli E; Boiocchi M
    J Rheumatol; 1994 Aug; 21(8):1497-501. PubMed ID: 7983653
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expression of BAFF (BLyS) in T cells infiltrating labial salivary glands from patients with Sjögren's syndrome.
    Lavie F; Miceli-Richard C; Quillard J; Roux S; Leclerc P; Mariette X
    J Pathol; 2004 Apr; 202(4):496-502. PubMed ID: 15095277
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lymphoproliferative disorders in Japanese patients with Sjögren's syndrome.
    Sugai S; Shimizu S; Konda S
    Scand J Rheumatol Suppl; 1986; 61():118-22. PubMed ID: 3473620
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Malignant lymphoma in primary Sjögren's syndrome: a multicenter, retrospective, clinical study by the European Concerted Action on Sjögren's Syndrome.
    Voulgarelis M; Dafni UG; Isenberg DA; Moutsopoulos HM
    Arthritis Rheum; 1999 Aug; 42(8):1765-72. PubMed ID: 10446879
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long term remission of Sjögren's syndrome associated aggressive B cell non-Hodgkin's lymphomas following combined B cell depletion therapy and CHOP (cyclophosphamide, doxorubicin, vincristine, prednisone).
    Voulgarelis M; Giannouli S; Tzioufas AG; Moutsopoulos HM
    Ann Rheum Dis; 2006 Aug; 65(8):1033-7. PubMed ID: 16322082
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.